Alper Sevinç

Alper Sevinç

MedicalPark - İstanbul / Türkiye
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 5294353
person_outline Alper Sevinç's MOST POPULAR ARTICLES
1-) Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trialM Martin, FA Holmes, B Ejlertsen, S Delaloge, B Moy, H Iwata, ...The lancet oncology 18 (12), 1688-1700, 20176482017
2-) Comparison of serum NO, TNF-α, IL-1β, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitusS Doganay, C Evereklioglu, H Er, Y Türköz, A Sevinc, N Mehmet, H ŞavliEye 16 (2), 163-170, 20024052002
3-) Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitusHM Turk, A Sevinc, C Camci, A Cigli, S Buyukberber, H Savli, N BayraktarActa diabetologica 39, 117-122, 20021762002
4-) Relationship between hopelessness, loneliness, and perceived social support from family in Turkish patients with cancerS Pehlivan, O Ovayolu, N Ovayolu, A Sevinc, C CamciSupportive Care in Cancer 20, 733-739, 20121642012
5-) Cancer trends and incidence and mortality patterns in TurkeyHH Yılmaz, N Yazıhan, D Tunca, A Sevinc, EÖ Olcayto, N Özgül, ...Japanese journal of clinical oncology 41 (1), 10-16, 20111592011